Information card for entry 2242677
| Chemical name |
(3a<i>R</i>*,7a<i>S</i>*)-2-(2,6-Dioxopiperidin-3-yl)hexahydro-1<i>H</i>-isoindole-1,3(2<i>H</i>)-dione |
| Formula |
C13 H16 N2 O4 |
| Calculated formula |
C13 H16 N2 O4 |
| SMILES |
O=C1N(C(=O)[C@H]2[C@@H]1CCCC2)[C@@H]1C(=O)NC(=O)CC1.O=C1N(C(=O)[C@@H]2[C@H]1CCCC2)[C@H]1C(=O)NC(=O)CC1 |
| Title of publication |
Crystal structure of the thalidomide analog (3a<i>R</i>*,7a<i>S</i>*)-2-(2,6-dioxopiperidin-3-yl)hexahydro-1<i>H</i>-isoindole-1,3(2<i>H</i>)-dione |
| Authors of publication |
Hijji, Yousef; Benjamin, Ellis; Jasinski, Jerry P.; Butcher, Ray J. |
| Journal of publication |
Acta Crystallographica Section E |
| Year of publication |
2018 |
| Journal volume |
74 |
| Journal issue |
11 |
| Pages of publication |
1595 - 1598 |
| a |
11.4519 ± 0.0003 Å |
| b |
9.237 ± 0.0003 Å |
| c |
11.8727 ± 0.0004 Å |
| α |
90° |
| β |
90.475 ± 0.003° |
| γ |
90° |
| Cell volume |
1255.87 ± 0.07 Å3 |
| Cell temperature |
123 ± 2 K |
| Ambient diffraction temperature |
123 ± 2 K |
| Number of distinct elements |
4 |
| Space group number |
14 |
| Hermann-Mauguin space group symbol |
P 1 21/c 1 |
| Hall space group symbol |
-P 2ybc |
| Residual factor for all reflections |
0.0674 |
| Residual factor for significantly intense reflections |
0.0663 |
| Weighted residual factors for significantly intense reflections |
0.2053 |
| Weighted residual factors for all reflections included in the refinement |
0.2076 |
| Goodness-of-fit parameter for all reflections included in the refinement |
1.187 |
| Diffraction radiation wavelength |
1.54178 Å |
| Diffraction radiation type |
CuKα |
| Has coordinates |
Yes |
| Has disorder |
No |
| Has Fobs |
Yes |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/2242677.html